158 related articles for article (PubMed ID: 6119765)
1. Placental transfer of sulphasalazine and sulphapyridine and some of its metabolites.
Järnerot G; Into-Malmberg MB; Esbjörner E
Scand J Gastroenterol; 1981; 16(5):693-7. PubMed ID: 6119765
[TBL] [Abstract][Full Text] [Related]
2. Albumin reserve for binding of bilirubin in maternal and cord serum under treatment with sulphasalazine.
Järnerot G; Andersen S; Esbjörner E; Sandström B; Brodersen R
Scand J Gastroenterol; 1981; 16(8):1049-55. PubMed ID: 6121372
[TBL] [Abstract][Full Text] [Related]
3. Comparative pharmacokinetics of sulphasalazine and sulphapyridine after rectal and oral administration to patients with ulcerative colitis.
Allgayer H; Kruis W; Eisenburg J; Paumgartner G
Eur J Clin Pharmacol; 1984; 26(2):275-7. PubMed ID: 6144549
[TBL] [Abstract][Full Text] [Related]
4. Sulphasalazine and sulphapyridine serum levels in children to mothers treated with sulphasalazine during pregnancy and lactation.
Esbjörner E; Järnerot G; Wranne L
Acta Paediatr Scand; 1987 Jan; 76(1):137-42. PubMed ID: 2882643
[TBL] [Abstract][Full Text] [Related]
5. Sulphasalazine treatment during breast feeding.
Järnerot G; Into-Malmberg MB
Scand J Gastroenterol; 1979; 14(7):869-71. PubMed ID: 44005
[TBL] [Abstract][Full Text] [Related]
6. Acetylation polymorphism of sulfapyridine in patients with ulcerative colitis and Crohn's disease.
Das KM; Eastwood MA
Clin Pharmacol Ther; 1975 Nov; 18(5 Pt 1):514-20. PubMed ID: 241531
[TBL] [Abstract][Full Text] [Related]
7. Placental and mammary transfer of sulphasalazine.
Khan AK; Truelove SC
Br Med J; 1979 Dec; 2(6204):1553. PubMed ID: 43760
[No Abstract] [Full Text] [Related]
8. Steady-state kinetics of 5-aminosalicylic acid and sulfapyridine during sulfasalazine prophylaxis in ulcerative colitis.
Bondesen S; Nielsen OH; Schou JB; Jensen PH; Lassen LB; Binder V; Krasilnikoff PA; Danø P; Hansen SH; Rasmussen SN
Scand J Gastroenterol; 1986 Aug; 21(6):693-700. PubMed ID: 2875518
[TBL] [Abstract][Full Text] [Related]
9. [Appearance of sulfasalazine and sulfapyridine in breast milk and in the placental barrier as well as the effect of both substances on bilirubin binding to albumin].
Järnerot G
Z Gastroenterol Verh; 1981 Jun; 19():27-8. PubMed ID: 6168129
[No Abstract] [Full Text] [Related]
10. Saliva: plasma concentration relationships for sulphapyridine following sulphasalazine administration to normal volunteers and patients with inflammatory bowel disease.
Day JM; Houston JB
Br J Clin Pharmacol; 1980 Jan; 9(1):91-4. PubMed ID: 6101957
[No Abstract] [Full Text] [Related]
11. [Individualized sulfasalazine treatment of ulcerative colitis and monitoring of patient compliance by determining sulfapyridine serum concentration].
Klugmann HJ; Giehler B; Lohmann D; Schiedewitz W
Gastroenterol J; 1990; 49(4):160-4. PubMed ID: 1970478
[TBL] [Abstract][Full Text] [Related]
12. Further studies of sulphasalazine metabolism in the treatment of ulcerative colitis.
Cowan GO; Das KM; Eastwood MA
Br Med J; 1977 Oct; 2(6094):1057-9. PubMed ID: 21720
[TBL] [Abstract][Full Text] [Related]
13. [Determination of sulfapyridine levels in serum--a possibility for the control of dose related therapy with sulfasalazine].
Eitner K; Reinicke C; Hippius M
Dtsch Z Verdau Stoffwechselkr; 1984; 44(6):282-8. PubMed ID: 6151895
[TBL] [Abstract][Full Text] [Related]
14. Sulfapyridine metabolites in children with inflammatory bowel disease receiving sulfasalazine.
Goldstein PD; Alpers DH; Keating JP
J Pediatr; 1979 Oct; 95(4):638-40. PubMed ID: 39125
[TBL] [Abstract][Full Text] [Related]
15. [Estimations of the serum levels of sulfapyridine on patients treated with sulfasalazin (author's transl)].
Eitner K; Hippius M; Reinicke C
Dtsch Z Verdau Stoffwechselkr; 1982; 42(1):14-9. PubMed ID: 6122556
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic efficacy of sulfasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease.
Klotz U; Maier K; Fischer C; Heinkel K
N Engl J Med; 1980 Dec; 303(26):1499-502. PubMed ID: 6107853
[TBL] [Abstract][Full Text] [Related]
17. [Ulcerative colitis in children. Levels of salicylazosulfapyridine and sulfapyridine during treatment].
Guastavino E; Litwin NH; Heffes Nahmod L; Licastro R
Acta Gastroenterol Latinoam; 1988; 18(2):107-13. PubMed ID: 2908013
[TBL] [Abstract][Full Text] [Related]
18. Salivary excretion and pharmacokinetics of sulfapyridine after sulfasalazine.
Bates TR; Blumenthal HP; Pieniaszek HJ
Clin Pharmacol Ther; 1977 Dec; 22(6):917-27. PubMed ID: 21768
[TBL] [Abstract][Full Text] [Related]
19. Hemolysis during salicylazosulfapyridine therapy.
van Hees PA; van Elferen LW; van Rossum JM; van Tongeren JH
Am J Gastroenterol; 1978 Nov; 70(5):501-5. PubMed ID: 33552
[TBL] [Abstract][Full Text] [Related]
20. The disposition and metabolism of sulphasalazine (salicylazosulphapyridine) in man.
Azadkhan AK; Truelove SC; Aronson JK
Br J Clin Pharmacol; 1982 Apr; 13(4):523-8. PubMed ID: 6121576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
